|
TheSUBWAY Investor Forum!
Registration is FREE. If there is a stock you would like to see added to TheSUBWAY's forum, EMAIL US HERE and we will add it for you.
The Intent of this Forum is to create an objective community to discuss Stocks and share information between investors!
|
Posted by TheSUBWAY-01 on 08-20-08 10:17 AM
This morning we are looking for ROYL ($6.80 at time of this writing) to go higher. It recently bounced off the 200 day and is right under the 50 day:
See our charts here:
http://stock-promoter.thesubway.com/thesubway-clients/roy l-is-pick-of-the-day/362
The MACD is turning positive:
Institutional buying is not in ROYL, but we are looking at ROYL only for a quick trade. It is above resistance though as seen on our PHILS X1 & X2:
Our DAILY chart is looking very good, note the "W" with the right side being higher signalling a possible support level for the morning:
Our 15 MINUTE chart seems to be in a range and we are looking for a breakout to the upside:
The WEEKLY chart is looking like it could be ready for turn in momemtum:
NOTE - The Stochastic is looking very good for ROYL:
|
Posted by TheSUBWAY-01 on 08-19-08 10:16 AM
XFML chart is looking good this morning, riding the back of yesterdays positive news:
http://stock-promoter.thesubway.com/thesubway-clients/xfm l-pick-of-the-day/351
http://stock-promoter.thesubway.com/wp-content/uploads/20 08/08/xfml-chart.png
NEWS:
Xinhua Finance Media Limited ("XFMedia" or "the Company"; Nasdaq: XFML), a leading media group in China, today announced its unaudited financial results for the second quarter ended June 30, 2008.
"Despite a challenging operating environment for the quarter, we are proud to announce adjusted EPS expectations above our Q2 guidance," said Ms. Fredy Bush, XFMedia's Chief Executive Officer.
"The Broadcast Group continues to deliver high margins, and we intend to further invest and expand the television business with a particular focus on sports. We believe this will be a significant driving force to our business over the next several years," Ms. Bush added.
"We expect our future growth to be driven by the expansion of our media assets and distribution channels, and the integration and coordination of such efforts across our operating groups. Our television viewer demographics are very strong and combined with our existing core competence, XFMedia today is able to penetrate a significant group of households in China, providing us with a strategic entry point to build on our advertising revenue," Ms. Bush said.
|
Posted by TheSUBWAY-01 on 08-18-08 10:22 AM
Pluristem Therapeutics Inc. (Nasdaq:PSTI)(DAX:PJT), a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for a variety of degenerative, ischemic and autoimmune indications, announces that William R. Prather RPh, MD, Sr. VP Corporate Development, will present at the Fourth Annual Noble Financial Equity Conference at 12:30 p.m. (Pacific) on Tuesday, August 19, 2008 at the Loews Lake Las Vegas Resort, Nevada.
Full Release:
http://stock-promoter.thesubway.com/thesubway-clients/plu ristem-therapeutics-to-pr esent-at-the-noble...
|
Posted by TheSUBWAY-01 on 08-13-08 10:49 AM
This morning we are looking at BLDP, It is above the 25, 50, 200 day moving averages, The Stochastics in the above chart are showing an overbought condition, but our longer term Stochastic indicator is showing BLDP to be in an uptrend, Our Phil's X2 chart is also showing there to be institutional buying in the stock as it is blue, Our Phil's X1 chart also shows that there is support at $4.38, which is right below where BLDP is trading now, Our 15 minute / weekly chart is also showing signs of being bullish as the weekly trend is up, We are looking at BLDP for a shorter term trade with a stop right under the support level. Good Luck Trading, See You on the Charts...
To see our charts used in this trade, visit this link:
http://stock-promoter.thesubway.com/thesubway-clients/bld p-is-pick-of-the-day-char t-is-looking-bulli...
|
Posted by TheSUBWAY-01 on 08-12-08 09:38 AM
All Asia Licensing Inc. (Pink Sheets:AASI), Friday announced that it entered into a Letter of Intent with an international bio research and marketing firm to manufacture and distribute in China the research company's proprietary cattle test for BSE (Bovine Spongiform Encephalopathy), better known as "Mad Cow" Disease.
"Assuming the consummation of a final agreement, I would anticipate that the 50-50 sharing arrangement may result in annual revenue between $100 million and $150 million for All Asia once the system is rolled out across China," according to Anthony Lee, CEO of All Asia Licensing.
AASI NEWS -
http://investor-forum.thesubway.com/small-cap-forum/showt opic.php?tid/1092/
|
Posted by TheSUBWAY-01 on 08-11-08 08:41 AM
All Asia Licensing Inc. (Pink Sheets: AASI), Friday announced that it entered into a Letter of Intent with an international bio research and marketing firm to manufacture and distribute in China the research company's proprietary cattle test for BSE (Bovine Spongiform Encephalopathy), better known as "Mad Cow" Disease.
Full News:
http://investor-forum.thesubway.com/small-cap-forum/showt opic.php?tid/1092/
|
Posted by TheSUBWAY-01 on 08-11-08 08:20 AM
Pluristem Therapeutics Inc. (NasdaqCM:PSTI) (DAX:PJT) a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for a variety of degenerative, ischemic and autoimmune indications, today announced that the Company's PLacental eXpanded (PLX-MS) cells have demonstrated in vivo efficacy in the prevention of Multiple Sclerosis (MS). PLX cells are Pluristem's placental-derived mesenchymal stromal cells (MSCs) that have been expanded in the Company's proprietary PluriX(TM) 3-D bioreactor.
Full News:
http://investor-forum.thesubway.com/small-cap-forum/showt opic.php?fid/132/tid/1091/pid/ 3577/
|
Home Page RSS Syndication from SeekingAlpha.com
|
|